Simon Spazzapan

5PUBLICATIONS
65CO-AUTHORS
Tumour immunologyPlanning and decision makingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 17, 2026
Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer.

|Dec 24, 2025
DonnaRosa Project: Exploring Informal Communication Practices Among Breast Cancer Specialists.

Antonella Ferro, Flavia Atzori, Catia Angiolini

|Jan 11, 2024
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study.

Marina Elena Cazzaniga, Paolo Pronzato, Domenico Amoroso

|Dec 15, 2022
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.

Olivia Pagani, Barbara A Walley, Gini F Fleming

|Apr 25, 2020
Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer.

Giulia Brisotto, Eva Biscontin, Elisabetta Rossi

Pageof 1

Frequent Collaborators

2 joint publications

Alberto Zambelli

2 joint publications

Antonella Ferro

2 joint publications

Filippo Giovanardi

2 joint publications

Donata Sartori